Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention

Vivek Mehta(Swedish Medical Center)

International Journal of Radiation Oncology*Biology*Physics

June 18, 2005

10.1016/j.ijrobp.2005.03.047

Cited by 413

Abstract

Related Papers

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

Stefan L.S. Kwa, Joos V. Lebesque, Jacqueline Theuws et al.|International Journal of Radiation Oncology*Biology*Physics|1998|754

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study.

Branislav Jeremić, Yuta Shibamoto, Ljubiša Aćimović et al.|Journal of Clinical Oncology|1996|364

Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial

James A. Hayman, Mary K. Martel, Randall K. Ten Haken et al.|Journal of Clinical Oncology|2001|325

Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study

T. Rancati|Radiotherapy and Oncology|2003|278

Radiation-induced and chemotherapy-induced pulmonary injury

Syed H. Abid, Vikas Malhotra, Michael C. Perry|Current Opinion in Oncology|2001|276